Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Spratt, Tiffany Chan, L. Waldron, C. Speers, F. Feng, O. Ogunwobi, J. Osborne (2016)
Racial/Ethnic Disparities in Genomic Sequencing.JAMA oncology, 2 8
Sue Richards, Nazneen Aziz, S. Bale, D. Bick, Soma Das, J. Gastier-Foster, W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H. Rehm (2015)
Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in medicine : official journal of the American College of Medical Genetics, 17
(2014)
Risk-reducing salpingooophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
S. O’Neill, C. Rini, Rachel Goldsmith, H. Valdimarsdottir, L. Cohen, M. Schwartz (2009)
Distress among women receiving uninformative BRCA1/2 results: 12‐month outcomesPsycho‐Oncology, 18
R. Lacour, M. Daniels, S. Westin, L. Meyer, C. Burke, K. Burns, Shiney Kurian, Nicki Webb, T. Pustilnik, K. Lu (2008)
What women with ovarian cancer think and know about genetic testing.Gynecologic oncology, 111 1
(2008)
Hereditary Breast Cancer Clinical Study Group. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Are physician recommendations for BRCA 1 / 2 testing in patients with breast
C. Marchetti, F. Felice, I. Palaia, G. Perniola, A. Musella, D. Musio, L. Muzii, V. Tombolini, P. Panici (2014)
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriersBMC Women's Health, 14
J. Struewing, P. Hartge, S. Wacholder, Sonya Baker, M. Berlin, M. McAdams, Michelle Timmerman, L. Brody, M. Tucker (1997)
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.The New England journal of medicine, 336 20
M. Daly, R. Pilarski, Michael Berry, S. Buys, Meagan Farmer, S. Friedman, J. Garber, N. Kauff, S. Khan, C. Klein, W. Kohlmann, A. Kurian, J. Litton, L. Madlensky, S. Merajver, K. Offit, T. Pal, Gwen Reiser, K. Shannon, E. Swisher, S. Vinayak, Nicoleta Voian, J. Weitzel, M. Wick, G. Wiesner, M. Dwyer, S. Darlow (2017)
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Journal of the National Comprehensive Cancer Network : JNCCN, 15 1
A. Kurian, K. Ward, N. Howlader, D. Deapen, A. Hamilton, A. Mariotto, Daniel Miller, Lynne Penberthy, S. Katz (2019)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37 15
(2018)
This study shows how the increasing use of multiple-gene sequencing has widened the racial/ethnic VUS divide
Evan Hall, Divya Parikh, Tanya Gupta, J. Caswell, M. Mills, K. Kingham, Rachel Koff, J. Ford, A. Kurian (2017)
Pathogenic germline mutations in emerging cancer genes: What happens after panel testing?Journal of Clinical Oncology, 35
(2017)
Woman sues after unnecessary mastectomy and hysterectomy | Time
Mitzi Murray, Felecia Cerrato, R. Bennett, G. Jarvik (2011)
Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: Variant reclassification and surgical decisionsGenetics in Medicine, 13
A. Kurian, Yun Li, A. Hamilton, K. Ward, S. Hawley, M. Morrow, M. McLeod, R. Jagsi, S. Katz (2017)
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 20
H. Stähelin (1994)
GuidelinesCommunicating Science
S. Macklin, N. Durand, P. Atwal, S. Hines (2017)
Observed frequency and challenges of variant reclassification in a hereditary cancer clinicGenetics in Medicine, 20
A. Manrai, B. Funke, H. Rehm, M. Olesen, B. Maron, Peter Szolovits, D. Margulies, J. Loscalzo, I. Kohane (2016)
Genetic Misdiagnoses and the Potential for Health Disparities.The New England journal of medicine, 375 7
H. Thompson, Katarina Sussner, M. Schwartz, Tiffany Edwards, A. Forman, Lina Jandorf, K. Brown, D. Bovbjerg, H. Valdimarsdottir (2012)
Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.Genetic testing and molecular biomarkers, 16 11
Scott Turner, Smita Rao, R. Morgan, Cindy Vnencak-Jones, Georgia Wiesner (2018)
The impact of variant classification on the clinical management of hereditary cancer syndromesGenetics in Medicine, 21
(2016)
This study is a large population-based assessment of potential causes for observed racial disparities in genetic testing that shows differences in physician recommendation
D. Cragun, A. Weidner, Courtney Lewis, D. Bonner, Jongphil Kim, S. Vadaparampil, T. Pal (2017)
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivorsCancer, 123
A. Kurian, K. Griffith, A. Hamilton, K. Ward, M. Morrow, S. Katz, R. Jagsi (2017)
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast CancerJAMA, 317
K. Armstrong, B. Weber, J. Stopfer, K. Calzone, M. Putt, J. Coyne, J. Schwartz (2002)
Early use of clinical BRCA1/2 testing: Associations with race and breast cancer riskAmerican Journal of Medical Genetics Part A, 117A
Mavis Machirori, C. Patch, A. Metcalfe (2019)
Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.European journal of medical genetics, 62 5
Jenny Chang, S. Seng, June Yoo, Pamela Equivel, S. Lum (2019)
Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel TestingAnnals of Surgical Oncology, 26
This study identified disparities in discussion of genetic testing and cancer risk management in a large and diverse population of women with history of breast cancer
J. Welsh, T. Hoskin, C. Day, Abigail Thomas, Jodie Cogswell, F. Couch, J. Boughey (2017)
Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 GenesAnnals of Surgical Oncology, 24
A. McCarthy, Mirar Bristol, Tracey Fredricks, L. Wilkins, Irene Roelfsema, K. Liao, J. Shea, P. Groeneveld, S. Domchek, K. Armstrong (2013)
Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population‐based studyCancer, 119
L. Meyer, Meaghan Anderson, R. Lacour, Anuj Suri, M. Daniels, D. Urbauer, G. Nogueras-Gonzalez, K. Schmeler, D. Gershenson, K. Lu (2010)
Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed OpportunitiesObstetrics & Gynecology, 115
S. Plon, H. Cooper, B. Parks, S. Dhar, P. Kelly, A. Weinberg, S. Staggs, Tao Wang, S. Hilsenbeck (2011)
Genetic testing and cancer risk management recommendations by physicians for at-risk relativesGenetics in Medicine, 13
J. Burns, P. Jean-Pierre (2018)
Disparities in the Diagnosis of Hypertrophic Obstructive Cardiomyopathy: A Narrative Review of Current LiteratureCardiology Research and Practice, 2018
A. Kurian, K. Ward, A. Hamilton, D. Deapen, P. Abrahamse, I. Bondarenko, Yun Li, S. Hawley, M. Morrow, R. Jagsi, S. Katz (2018)
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast CancerJAMA Oncology, 4
Caren Smith, S. Fullerton, KEITH DOOKERAN, H. Hampel, A. Tin, N. Maruthur, J. Schisler, J. Henderson, K. Tucker, J. Ordovás (2016)
Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.Health affairs, 35 8
L. Schmidt, T. Greenfield, N. Mulia (2006)
Unequal TreatmentAlcohol Research & Health, 29
(2019)
This study is the most recent and largest population-based study that identified and characterized racial/ethnic GT disparities among ovarian cancer patients
Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care
A. Kurian, K. Ward, P. Abrahamse, A. Hamilton, D. Deapen, M. Morrow, S. Katz (2019)
Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort.Journal of Clinical Oncology
D. Levy, S. Byfield, C. Comstock, J. Garber, S. Syngal, W. Crown, Alexandra Shields (2011)
Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at riskGenetics in Medicine, 13
E. Franzese, Sara Centonze, A. Diana, Francesca Carlino, L. Guerrera, M. Napoli, F. Vita, S. Pignata, F. Ciardiello, M. Orditura (2019)
PARP inhibitors in ovarian cancer.Cancer treatment reviews, 73
S. Katz, I. Bondarenko, K. Ward, A. Hamilton, M. Morrow, A. Kurian, T. Hofer (2018)
Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast CancerJAMA Surgery, 153
T. Tuttle, E. Habermann, Erin Grund, T. Morris, B. Virnig (2007)
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 33
(2001)
This study identifies how physicians' attitudes about genetic testing and counseling can be a potential driver of disparities in GT rates
T. Slavin, S. Manjarrez, C. Pritchard, S. Gray, J. Weitzel (2019)
The effects of genomic germline variant reclassification on clinical cancer careOncotarget, 10
A. Kurian, C. Friese, I. Bondarenko, R. Jagsi, Yun Li, A. Hamilton, K. Ward, S. Katz (2017)
Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and ConsequencesJAMA Oncology, 3
J. Chern, Sarah Lee, M. Frey, Jessica Lee, S. Blank (2019)
The influence of BRCA variants of unknown significance on cancer risk management decision-makingJournal of Gynecologic Oncology, 30
M. Ndugga-Kabuye, Rachel Issaka (2019)
Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to EuropeanFamilial Cancer, 18
Chloe Mighton, G. Charames, Marina Wang, Kathleen-Rose Zakoor, Andrew Wong, Salma Shickh, N. Watkins, Matthew Lebo, Y. Bombard, J. Lerner-Ellis (2019)
Variant classification changes over time in BRCA1 and BRCA2Genetics in Medicine, 21
(2017)
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FHTM patient
Marilyn Huang, P. Kamath, M. Schlumbrecht, Feng Miao, D. Driscoll, S. Oldak, B. Slomovitz, T. Koru-Sengul, S. George (2019)
Identifying disparities in germline and somatic testing for ovarian cancer.Gynecologic oncology, 153 2
J. Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, H. Cox, K. Brown, Melissa Aston, L. Esterling, S. Manley, Theodora Ross (2018)
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJAMA, 320
N. Elsayegh, Rachel Webster, A. Barrera, Heather Lin, H. Kuerer, J. Litton, I. Bedrosian, B. Arun (2018)
Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancerCancer Medicine, 7
H. Pederson, D. Gopalakrishnan, R. Noss, Courtney Yanda, C. Eng, S. Grobmyer (2018)
Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.Journal of the American College of Surgeons, 226 4
J. Litton, H. Rugo, J. Ettl, S. Hurvitz, A. Gonçalves, Kyung-Hun Lee, L. Fehrenbacher, R. Yerushalmi, L. Mina, Miguel Martín, H. Roché, Y. Im, R. Quek, D. Markova, I. Tudor, A. Hannah, W. Eiermann, J. Blum (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA MutationThe New England Journal of Medicine, 379
M. Hall, J. Reid, L. Burbidge, D. Pruss, A. Deffenbaugh, Cynthia Frye, R. Wenstrup, B. Ward, T. Scholl, W. Noll (2009)
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancerCancer, 115
J. Churpek, T. Walsh, Yonglan Zheng, Zakiya Moton, A. Thornton, Ming Lee, S. Casadei, Amanda Watts, Barbara Neistadt, M. Churpek, D. Huo, Cecilia Zvosec, Fang Liu, Q. Niu, Rafael Márquez, Jing Zhang, J. Fackenthal, M. King, O. Olopade (2014)
Inherited predisposition to breast cancer among African American womenBreast Cancer Research and Treatment, 149
L. Susswein, C. Skrzynia, L. Lange, J. Booker, M. Graham, J. Evans (2008)
Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 1
E. Manrriquez, J. Chapman, J. Mak, Amie Blanco, Lee-may Chen (2018)
Disparities in genetics assessment for women with ovarian cancer: Can we do better?Gynecologic oncology, 149 1
A. Azvolinsky (2013)
Supreme Court ruling broadens BRCA testing options.Journal of the National Cancer Institute, 105 22
S. Amrock, P. Duell, T. Knickelbine, S. Martin, Emily O'Brien, K. Watson, J. Mitri, I. Kindt, P. Shrader, S. Baum, L. Hemphill, C. Ahmed, Rolf Andersen, I. Kullo, Dervilla McCann, J. Larry, M. Murray, R. Fishberg, J. Guyton, K. Wilemon, M. Roe, D. Rader, C. Ballantyne, James Underberg, P. Thompson, D. Duffy, M. Linton, M. Shapiro, P. Moriarty, J. Knowles, Z. Ahmad (2017)
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.Atherosclerosis, 267
C. Ricker, Julie Culver, K. Lowstuter, D. Sturgeon, Julia Sturgeon, Christopher Chanock, W. Gauderman, K. McDonnell, G. Idos, S. Gruber (2016)
Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.Cancer genetics, 209 4
T. Delikurt, G. Williamson, V. Anastasiadou, H. Skirton (2014)
A systematic review of factors that act as barriers to patient referral to genetic servicesEuropean Journal of Human Genetics, 23
A. Kurian, D. Lichtensztajn, T. Keegan, D. Nelson, C. Clarke, S. Gomez (2014)
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.JAMA, 312 9
K. Childers, M. Maggard-gibbons, J. Macinko, C. Childers (2018)
National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian CancerJAMA Oncology, 4
(2018)
This study describes the nationwide distribution of GT for hereditary cancer risk in the United States
Jee-Soo Lee, Sohee Oh, Sue-Kyung Park, Min-Hyuk Lee, Jong Lee, Sung-Won Kim, B. Son, D. Noh, J. Lee, Hai‐Lin Park, M. Kim, Sung Cho, Young Lee, S. Park, M. Seong (2018)
Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohortJournal of Medical Genetics, 55
D. Kwon, H. Borno, Heather Cheng, A. Zhou, E. Small (2020)
Ethnic disparities among men with prostate cancer undergoing germline testing.Urologic oncology
Moriah Wright, V. Menon, Lindsay Taylor, M. Shashidharan, Twilla Westercamp, C. Ternent (2018)
Factors predicting reclassification of variants of unknown significance.American journal of surgery, 216 6
Y. Yap, Yen-Shen Lu, K. Tamura, J. Lee, E. Ko, Yeon-Hee Park, A. Cao, Ching-Hung Lin, M. Toi, Jiong Wu, Soo-Chin Lee (2019)
Insights Into Breast Cancer in the East vs the West: A Review.JAMA oncology
B. Smedley, Adrienne Stith, A. Nelson (2003)
Unequal treatment: confronting racial and ethnic disparities in health care.Journal of The National Medical Association, 94
K. Armstrong, Ellyn Micco, A. Carney, J. Stopfer, M. Putt (2005)
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.JAMA, 293 14
M. So, Tae-Dong Jeong, W. Lim, B. Moon, N. Paik, Seung Kim, J. Huh (2019)
Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesBreast Cancer, 26
A. McCarthy, Mirar Bristol, S. Domchek, P. Groeneveld, Younji Kim, U. Motanya, J. Shea, K. Armstrong (2016)
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 22
Jennifer Caswell-Jin, Tanya Gupta, Evan Hall, Iva Petrovchich, M. Mills, K. Kingham, Rachel Koff, N. Chun, P. Levonian, A. Lebensohn, J. Ford, A. Kurian (2017)
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer riskGenetics in Medicine, 20
Pathogenic and likely pathogenic variants in PALB 2 , CHEK 2 , and other known breast
K. Metcalfe, D. Birenbaum-Carmeli, J. Lubiński, J. Gronwald, H. Lynch, P. Møller, P. Ghadirian, W. Foulkes, J. Klijn, E. Friedman, C. Kim-sing, P. Ainsworth, B. Rosen, S. Domchek, T. Wagner, N. Tung, S. Manoukian, F. Couch, P. Sun, S. Narod (2008)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 122
S. Domchek, T. Friebel, C. Singer, D. Evans, H. Lynch, C. Isaacs, J. Garber, S. Neuhausen, E. Matloff, R. Eeles, G. Pichert, Laura t'veer, N. Tung, J. Weitzel, F. Couch, W. Rubinstein, P. Ganz, M. Daly, O. Olopade, G. Tomlinson, J. Schildkraut, J. Blum, T. Rebbeck (2010)
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.JAMA, 304 9
Gani Bajraktari, N. Pugliese, Andreina D’agostino, G. Rosa, P. Ibrahimi, L. Perçuku, M. Miccoli, G. Galeotti, I. Fabiani, R. Pedrinelli, M. Henein, F. Dini (2018)
Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure PatientsCardiology Research and Practice, 2018
M. Howard-McNatt, R. Schroll, G. Hurt, E. Levine (2011)
Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.American journal of surgery, 202 3
J. Weitzel, S. Neuhausen, A. Adamson, S. Tao, C. Ricker, Asaf Maoz, M. Rosenblatt, Bita Nehoray, S. Sand, L. Steele, G. Unzeitig, N. Feldman, Amie Blanco, D. Hu, S. Huntsman, D. Castillo, C. Haiman, T. Slavin, E. Ziv (2019)
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA‐negative Hispanics with breast cancerCancer, 125
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Purpose of ReviewDespite advances in testing for heritable cancer susceptibility gene mutations, health disparities persist. We review racial/ethnic and socioeconomic factors that affect access to genetic counseling and testing, which may influence the validity of results among diverse populations and the clinical utility of genetic testing.Recent FindingsDifferential access to genetic testing among racial/ethnic minorities including Hispanics and blacks compared with whites drives disparities in the clinical validity of results: specifically, variants of unknown significance (VUS) are notably more prevalent in minorities. Deficiencies in results interpretation by patients and providers are common with VUS, which may engender disparities in clinical utility.SummaryThere is evidence of racial/ethnic disparities in genetic testing access and the clinical validity of results, which are threats to the clinical utility of testing for all populations. Concerted efforts are needed to decrease disparities in germline cancer genetic testing and results’ interpretation and management.
Current Breast Cancer Reports – Springer Journals
Published: Jun 12, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.